Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Sep;14(3):333–339. doi: 10.1111/j.1365-2125.1982.tb01988.x

The influence of the menstrual cycle on the metabolism and clearance of methaqualone.

K Wilson, M Oram, C E Horth, D Burnett
PMCID: PMC1427643  PMID: 7126410

Abstract

1 The rate of methaqualone metabolism in women was shown to be significantly increased at the time of ovulation. 2 The apparent first order rate constants for the formation of five C-monohydroxy metabolites of methaqualone on day 15 of the menstrual cycle were approximately double that on day 1. 3 The N-oxidation of methaqualone showed considerable inter-individual variation in its sensitivity to the menstrual cycle, and in a group of ten women the difference in N-oxide excretion between days 1 and 15 was not statistically significant. 4 The serum clearance of methaqualone on day 15 was higher (mean value 94.6 ml min-1 on day 1, 176.0 ml min-1 on day 15), serum half-life shorter (mean t1/2 beta 16.3 h on day 1, 11.6 h on day 15) and the AUC alpha smaller (mean value 44.0 micrograms ml-1 h on day 1, 24.4 micrograms ml-1 h on day 15) than on day 1. 5 The relative importance of the five hydroxy metabolites was unchanged during the menstrual cycle but the C/N oxidation ratio was greater on day 15 than on day 1. 6 The data for methaqualone metabolism in a control group of men was similar to than in women on day 1 of a menstrual cycle.

Full text

PDF
333

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alván G., Lindgren J. E., Bogentoft C., Ericsson O. Plasma kinetics of methaqualone in man after single oral doses. Eur J Clin Pharmacol. 1973 Oct;6(3):187–190. doi: 10.1007/BF00558284. [DOI] [PubMed] [Google Scholar]
  2. Burnett D., Reynolds C. N., Wilson K., Francis J. R. Urinary excretion of c-hydroxy derivatives of methaqualone in man. Xenobiotica. 1976 Feb;6(2):125–134. doi: 10.3109/00498257609151621. [DOI] [PubMed] [Google Scholar]
  3. Bäckström T., Jorpes P. Serum phenytoin, phenobarbital, carbamazepine, albumin; and plasma estradiol, progesterone concentrations during the menstrual cycle in women with epilepsy. Acta Neurol Scand. 1979 Mar;59(2-3):63–71. doi: 10.1111/j.1600-0404.1979.tb02912.x. [DOI] [PubMed] [Google Scholar]
  4. Fraser H. S., Mucklow J. C., Bulpitt C. J., Khan C., Mould G., Dollery C. T. Environmental effects on antipyrine half-life in man. Clin Pharmacol Ther. 1977 Nov;22(5 Pt 2):799–808. doi: 10.1002/cpt1977225part2799. [DOI] [PubMed] [Google Scholar]
  5. Gustafsson J. A., Eneroth P., Hökfelt T., Mode A., Norstedt G., Skett P. Central control of hepatic steroid metabolism and "lactogenic" receptor. J Steroid Biochem. 1980 Jan;12:1–15. doi: 10.1016/0022-4731(80)90245-9. [DOI] [PubMed] [Google Scholar]
  6. Herz R., Koelz H. R., Haemmerli U. P., Benes I., Blum A. L. Inhibition of hepatic demethylation of aminopyrine by oral contraceptive steroids in humans. Eur J Clin Invest. 1978 Feb;8(1):27–30. doi: 10.1111/j.1365-2362.1978.tb00804.x. [DOI] [PubMed] [Google Scholar]
  7. Kellermann G., Luyten-Kellermann M., Horning M. G., Stafford M. Elimination of antipyrine and benzo[a]pyrene metabolism in cultured human lymphocytes. Clin Pharmacol Ther. 1976 Jul;20(1):72–80. doi: 10.1002/cpt197620172. [DOI] [PubMed] [Google Scholar]
  8. MACDONALD I. Gastric activity during the menstrual cycle. Gastroenterology. 1956 Apr;30(4):602–607. [PubMed] [Google Scholar]
  9. Manowitz P., Shull C. M. Methaqualone metabolism by rat liver microsomes. Res Commun Chem Pathol Pharmacol. 1976 Jan;13(1):27–39. [PubMed] [Google Scholar]
  10. Mode A., Eneroth P., Gustafsson J. A., Hökfelt T., Skett P. Effects of hypothalamic deafferentation at different levels on metabolism of hepatic steroids in rats. J Endocrinol. 1980 Jul;86(1):69–77. doi: 10.1677/joe.0.0860069. [DOI] [PubMed] [Google Scholar]
  11. Mode A., Norstedt G., Simic B., Eneroth P., Gustafsson J. A. Continuous infusion of growth hormone feminizes hepatic steroid metabolism in the rat. Endocrinology. 1981 Jun;108(6):2103–2108. doi: 10.1210/endo-108-6-2103. [DOI] [PubMed] [Google Scholar]
  12. Nayak R. K., Smyth R. D., Chamberlain J. H., Polk A., DeLong A. F., Herczeg T., Chemburkar P. B., Joslin R. S., Reavey-Cantwell N. H. Methaqualone pharmacokinetics after single- and multiple-dose administration in man. J Pharmacokinet Biopharm. 1974 Apr;2(2):107–121. doi: 10.1007/BF01061503. [DOI] [PubMed] [Google Scholar]
  13. Nebert D. W. Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolism. Br Med J (Clin Res Ed) 1981 Aug 22;283(6290):537–542. doi: 10.1136/bmj.283.6290.537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. O'Malley K., Crooks J., Duke E., Stevenson I. H. Effect of age and sex on human drug metabolism. Br Med J. 1971 Sep 11;3(5775):607–609. doi: 10.1136/bmj.3.5775.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Oram M., Wilson K., Burnett D. The influence of oral contraceptives on the metabolism of methaqualone in man. Br J Clin Pharmacol. 1982 Sep;14(3):341–345. doi: 10.1111/j.1365-2125.1982.tb01989.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Reinke L. A., O'Connor M. F., Piepho R. W., Stohs S. J. A comparison of the inductive effects of phenobarbital, methaqualone, and methyprylon on hepatic mixed function oxidase enzymes in the rat. Res Commun Chem Pathol Pharmacol. 1975 May;11(1):45–53. [PubMed] [Google Scholar]
  17. Riester E. F., Pantuck E. J., Pantuck C. B., Passananti G. T., Vesell E. S., Conney A. H. Antipyrine metabolism during the menstrual cycle. Clin Pharmacol Ther. 1980 Sep;28(3):384–391. doi: 10.1038/clpt.1980.177. [DOI] [PubMed] [Google Scholar]
  18. Roberts R. K., Desmond P. V., Wilkinson G. R., Schenker S. Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives. Clin Pharmacol Ther. 1979 Jun;25(6):826–831. doi: 10.1002/cpt1979256826. [DOI] [PubMed] [Google Scholar]
  19. Skett P., Gustafsson J. A. Hypothalamo-pituitary regulation of liver function. Med Biol. 1979;57(6):374–389. [PubMed] [Google Scholar]
  20. Wilson K., Burnett D., Oram M., Reynolds C. T. The kinetics of the urinary excretion of the N-oxide and glucuronides of methaqualone in man. Eur J Drug Metab Pharmacokinet. 1981;6(4):289–295. doi: 10.1007/BF03189528. [DOI] [PubMed] [Google Scholar]
  21. Wilson K., Reynolds C. N., Burnett D. Inter- and intra-individual variation in the metabolism of methaqualone in man after a single oral dose. Eur J Clin Pharmacol. 1978 Jun 19;13(4):291–297. doi: 10.1007/BF00716365. [DOI] [PubMed] [Google Scholar]
  22. Wójcicki J., Gawrońska-Szklarz B., Kazimierczyk J., Baskiewicz Z., Raczyński A. Comparative pharmacokinetics of paracetamol in men and women considering follicular and luteal phases. Arzneimittelforschung. 1979;29(2):350–352. [PubMed] [Google Scholar]
  23. Ziegler D. M., McKee E. M., Poulsen L. L. Microsomal flavoprotein-catalyzed N-oxidation of arylamines. Drug Metab Dispos. 1973 Jan-Feb;1(1):314–321. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES